lu 135252 has been researched along with Aortic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dao, HH; Essalihi, R; McKee, MD; Moreau, P; Ouellette, V | 1 |
| Bouvet, C; Dao, HH; Essalihi, R; Gilbert, LA; McKee, MD; Moreau, P; Semerjian, Y | 1 |
2 other study(ies) available for lu 135252 and Aortic Diseases
| Article | Year |
|---|---|
Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin?
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Calcinosis; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Macrophages; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteoclasts; Osteopontin; Osteoprotegerin; Phenotype; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptors, Endothelin; Vitamin K 1; Warfarin | 2004 |
Regression of medial elastocalcinosis in rat aorta: a new vascular function for carbonic anhydrase.
Topics: Animals; Aorta; Aortic Diseases; Calcinosis; Calcium; Carbonic Anhydrase II; Carbonic Anhydrase IV; Carotid Arteries; Endothelin Receptor Antagonists; Enzyme Activation; Hemodynamics; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Remission Induction; Vitamin K 1; Warfarin | 2005 |